Schedule 4.16 to Purchase Agreement – Patent Status of BLSI Technologies

Contract Categories: Business Finance › Purchase Agreements
Summary

This document is a schedule to a purchase agreement between the parties, listing the patent status of various BLSI Technologies. It details specific technologies, their patent application and issuance years, serial and patent numbers, titles, and comments on their use or manufacturing. The schedule notes that all patents have been filed and maintained in major territories worldwide, but issued patents refer only to the US, with foreign patents still pending.

Read More Arrow
EX-10.3 4 0004.txt SCHEDULE 4.16 TO THE PURCHASE AGREEMENT Exhibit 10.3 Schedule 4.16 PATENT STATUS OF BLSI TECHNOLOGIES
Schedule 4.16 Application Year Year Serial Patent Technology filed issued Number Number Title Comments ==================================================================================================================================== Therafectin N/A 1994 N/A 5,298,494 Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof Use/manufacturing - ------------------------------------------------------------------------------------------------------------------------------------ Altropane N/A 1996 N/A 5,493,026 Substituted 2-Carboxyalkyl-3-(Flurophenyl)-8- (3-Halopropen-2-YL) Nortropanes Composition and their use as imaging for neurodegenerative disorders - ------------------------------------------------------------------------------------------------------------------------------------ Troponin N/A 1998 N/A 5,837,680 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of Use their use to inhibit angiogenesis - ------------------------------------------------------------------------------------------------------------------------------------ AF-1 1997 08/916,642 Trophic factors for CNS Regeneration Use/composition - ------------------------------------------------------------------------------------------------------------------------------------ Inosine 1997 08/921,902 Methods for Modulating the Axonal Outgrowth of CNS Neurons Use - ------------------------------------------------------------------------------------------------------------------------------------ C-maf 1996 08/636,602 Methods and Compositions for Regulating T-cell subsets Composition/Use by Modulating Transcription Factor Activity - ------------------------------------------------------------------------------------------------------------------------------------
All patents have been filed and maintained in all major territories worldwide. In the case of issued patents, these refer to US only. Foreign patents have not yet been issued.